Special Issue "Chitosan Nanoparticles in Drug Delivery"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (10 March 2020).
Interests: lipid-based drug delivery; lipid nanoparticles; polymer nanoparticles; vaccine adjuvants; immunology; oncology
Chitosan is a polysaccharide derived by deactylation of the naturally occurring polymer chitin, which occurs in crustacean shells. Chitosan is widely available commercially in various forms, and its chemistry lends itself to functionalization. Due to its excellent biocompatibility, biodegradability and versatility, chitosan has been applied to diverse drug delivery systems for nearly every route of administration. The close relationship between the physical properties of the specific chitosan polymer used and its performance in drug delivery systems requires that we gain further understanding not only of advanced fabrication methodologies and key physical characterization parameters but also of biological interactions with chitosan at the cellular and systems level. This Special Issue of Pharmaceutics will give readers an overview and considerable depth on the current state of chitosan nanoparticle technology, application and analysis.
Dr. Ellen Wasan
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- nanoparticle fabrication
- nanoparticle characterization
- nanoparticle toxicology
- controlled drug release
- smart polymers
- targeted drug delivery
- gene therapy